文献速递妇产影像泌尿生殖技术与安全US

卵巢癌筛查:影像学挑战与改进机会

Screening for ovarian cancer: imaging challenges and opportunities for improvement.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-01-01

UKCTOCS 报告采用每年序贯多模式策略(追踪 CA125,升高后行超声)筛查使卵巢癌患者平均总死亡率降低,但多例 CA125 升高而超声正常导致手术延迟。侵袭性卵巢癌可能起源于输卵管伞端上皮且转移前仅部分可被超声检出,未来应聚焦侵袭性早期肿瘤特异特征、提高输卵管病变检出敏感性,并探索三阶段多模式筛查。

要点

  • CA125 升高而超声正常的情况可延迟手术干预,是假阴性相关因素。
  • 许多侵袭性卵巢癌可能起源于输卵管伞端上皮,该部位不易被超声成像。
  • 仅部分转移瘤在转移前达到超声可检出大小,年度超声可能漏检大量早期癌。

核心结论

  • 筛查中 CA125 升高但超声正常可延迟手术干预,是假阴性相关因素。
  • 侵袭性卵巢癌可能起源于输卵管伞端上皮,该部位不易成像;仅部分转移瘤在转移前达到超声可检出大小。
  • 未来改进筛查应聚焦侵袭性早期肿瘤的特异特征,并提高影像敏感性以检出输卵管病变。
  • 在血液检测阳性而超声阴性的病例中采用第三种模态的三阶段多模式筛查策略,可能有助于检出超声漏检的早期病例。

研究设计与样本

  • 本文为综述,围绕 UKCTOCS 年度序贯多模式筛查策略(追踪 CA125,升高后行超声)所报告的影像学挑战与改进机会进行讨论。

临床应用与阅片要点

  • 原文指出,CA125 升高而超声筛查正常的病例可延迟手术干预,是假阴性相关因素。
  • 原文提出,在血液检测阳性而超声阴性的病例中采用第三种模态的三阶段多模式筛查策略,可能有助于检出超声漏检的早期病例。

局限性

  • 原文指出,许多侵袭性卵巢癌被认为起源于输卵管伞端上皮,该部位不易被超声成像。
  • 原文指出,仅一部分转移瘤可能在转移前达到超声可检出大小,年度超声筛查可能漏检大量早期卵巢癌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) recently reported a reduction in the average overall mortality among ovarian cancer patients screened with an annual sequential, multimodal strategy that tracked biomarker CA125 over time, where increasing serum CA125 levels prompted ultrasound. However, multiple cases were documented wherein serum CA125 levels were rising, but ultrasound screens were normal, thus delaying surgical intervention. A significant factor which could contribute to false negatives is that many aggressive ovarian cancers are believed to arise from epithelial cells on the fimbriae of the fallopian tubes, which are not readily imaged. Moreover, because only a fraction of metastatic tumors may reach a sonographically-detectable size before they metastasize, annual screening with ultrasound may fail to detect a large fraction of early-stage ovarian cancers. The ability to detect ovarian carcinomas before they metastasize is critical and future efforts towards improving screening should focus on identifying unique features specific to aggressive, early-stage tumors, as well as improving imaging sensitivity to allow for detection of tubal lesions. Implementation of a three-stage multimodal screening strategy in which a third modality is employed in cases where the first-line blood-based assay is positive and the second-line ultrasound exam is negative may also prove fruitful in detecting early-stage cases missed by ultrasound.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Mathieu KB, Bedi DG, Thrower SL, et al. Screening for ovarian cancer: imaging challenges and opportunities for improvement. Ultrasound Obstet Gynecol. 2018. PMID: 28639753. doi:10.1002/uog.17557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。